The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus apatinib and chemotherapy as neoadjuvant therapy for triple negative breast cancer (TNBC): A single-arm, prospective phase II study (MA-BC-II-026).
 
Chunying Zhuang
No Relationships to Disclose
 
Xiaoxiao Liu
No Relationships to Disclose
 
Yuting Song
No Relationships to Disclose
 
Ping He
No Relationships to Disclose
 
Dan Zheng
No Relationships to Disclose
 
Xi Yan
No Relationships to Disclose
 
Xiaorong Zhong
No Relationships to Disclose
 
Tinglun Tian
No Relationships to Disclose
 
Bing Wei
No Relationships to Disclose
 
Yu Xin Xie
No Relationships to Disclose
 
Jie Chen
No Relationships to Disclose
 
Qing Lv
No Relationships to Disclose
 
Ting Luo
No Relationships to Disclose